Prognostic value of positron emission tomography/computed tomography metabolic parameters in assessing primary gastrointestinal diffuse large B-cell lymphoma

View at publisher Summarise with VIRAT
Authors: Fanli Lin, lin yu, Liang Cai, Pengqiang Wu
Cited by: 0
References: 28

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

PURPOSE: This study aimed to evaluate the prognostic significance of fluorine-18 ( 18 F) fluorodeoxyglucose PET/computed tomography (CT) metabolic parameters in patients with primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL). METHODS: We retrospectively analyzed 24 PGI-DLBCL patients treated with R-CHOP chemotherapy. Continuous variables were dichotomized at the median and compared using the t-test, whereas categorical variables [e.g. gender, cell origin (germinal center B-cell/non-germinal center B-cell)] were compared using the Chi-square test. Spearman correlation analysis was performed to examine relationships between metabolic parameters and potential prognostic factors. Univariate Kaplan-Meier survival analysis and multivariate Cox regression were used to identify independent prognostic factors for progression-free survival and overall survival. Prognostic differences among risk groups were also assessed. RESULTS: Total lesion glycolysis (TLG), lactate dehydrogenase, International Prognostic Index (IPI), National Comprehensive Cancer Network-IPI, metabolic tumor volume (△MTV, representing changes in MTV between baseline and interim PET/CT), and clinical staging differed significantly between high and low-MTV groups (all P < 0.05).TLG, △MTV, lactate dehydrogenase, IPI score, National Comprehensive Cancer Network-IPI score, and clinical stage were significantly correlated with MTV (all P < 0.05). Receiver operating characteristic analysis indicated that MTV, standardized uptake value (△SUV max , changes in SUV max between baseline and interim PET/CT), TLG, and ΔMTV effectively predicted mid-term remission. Multivariate analysis identified MTV and ΔSUV max as independent predictors of progression-free survival ( P < 0.05), whereas ΔSUV max was independently associated with overall survival ( P < 0.05). Cox regression analysis revealed significant prognostic differences among subgroups ( P < 0.0001). CONCLUSION: MTV, △SUV max , TLG, and △MTV are effective for evaluating for mid-term remission in PGI-DLBCL patients. Among them, MTV and △SUV max serve as independent prognostic factors.

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Medical Imaging Techniques and Applications CNS Lymphoma Diagnosis and Treatment

Publication details

Journal / source
Nuclear Medicine Communications
Volume
47
Issue
7
Pages
807–813
Publication date
31 March 2026
Language
EN